About this Journal Submit a Manuscript Table of Contents
ISRN Urology
Volume 2014 (2014), Article ID 869610, 7 pages
http://dx.doi.org/10.1155/2014/869610
Research Article

Colicin E2 Expression in Lactobacillus brevis DT24, A Vaginal Probiotic Isolate, against Uropathogenic Escherichia coli

Institute of Science, Nirma University, Sarkhej-Gandhinagar Highway, Chharodi, Ahmedabad, Gujarat 382481, India

Received 19 September 2013; Accepted 14 November 2013; Published 4 February 2014

Academic Editors: V. Serretta, Y. Sumino, and E. Yilmaz

Copyright © 2014 Disha Trivedi et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. E. J. Dielubanza and A. J. Schaeffer, “Urinary tract infections in women,” Medical Clinics of North America, vol. 95, no. 1, pp. 27–41, 2011. View at Publisher · View at Google Scholar · View at Scopus
  2. B. Foxman, R. Barlow, H. D'Arcy, B. Gillespie, and J. D. Sobel, “Urinary tract infection: self-reported incidence and associated costs,” Annals of Epidemiology, vol. 10, no. 8, pp. 509–515, 2000. View at Publisher · View at Google Scholar · View at Scopus
  3. L. E. Nicolle, “Uncomplicated urinary tract infection in adults including uncomplicated pyelonephritis,” Urologic Clinics of North America, vol. 35, no. 1, pp. 1–12, 2008. View at Publisher · View at Google Scholar · View at Scopus
  4. D. E. Neal Jr., “Complicated urinary tract infections,” Urologic Clinics of North America, vol. 35, no. 1, pp. 13–22, 2008. View at Publisher · View at Google Scholar · View at Scopus
  5. B. Foxman, “Recurring urinary tract infection: incidence and risk factors,” The American Journal of Public Health, vol. 80, no. 3, pp. 331–333, 1990. View at Scopus
  6. R. Ikäheimo, A. Siitonen, T. Heiskanen et al., “Recurrence of urinary tract infection in a primary care setting: analysis of a 1-year follow-up of 179 women,” Clinical Infectious Diseases, vol. 22, no. 1, pp. 91–99, 1996. View at Scopus
  7. M. S. Litwin and C. S. Saigal, “Urologic diseases in America,” NIH Publication 07–5512, US Department of Health and Human Services, Public Health Service, National Institutes of Health, National Institute of Diabetes and Digestive and Kidney Diseases, US Government Printing Office, Washington, DC, USA, 2007.
  8. J. E. Delzell and M. L. Lefevre, “Urinary tract infections during pregnancy,” American Family Physician, vol. 61, no. 3, pp. 713–721, 2000. View at Scopus
  9. R. N. Jones, K. C. Kugler, M. A. Pfaller, and P. L. Winokur, “Characteristics of pathogens causing urinary tract infections in hospitals in North America: results from the SENTRY Antimicrobial Surveillance Program, 1997,” Diagnostic Microbiology and Infectious Disease, vol. 35, no. 1, pp. 55–63, 1999. View at Publisher · View at Google Scholar · View at Scopus
  10. G. G. Zhanel, J. A. Karlowsky, G. K. M. Harding et al., “A Canadian national surveillance study of urinary tract isolates from outpatients: comparison of the activities of trimethoprim-sulfamethoxazole, ampicillin, mecillinam, nitrofurantoin, and ciprofloxacin,” Antimicrobial Agents and Chemotherapy, vol. 44, no. 4, pp. 1089–1092, 2000. View at Publisher · View at Google Scholar · View at Scopus
  11. I. Connell, W. Agace, P. Klemm, M. Schembri, S. Mårild, and C. Svanborg, “Type 1 fimbrial expression enhances Escherichia coli virulence for the urinary tract,” Proceedings of the National Academy of Sciences of the United States of America, vol. 93, no. 18, pp. 9827–9832, 1996. View at Publisher · View at Google Scholar · View at Scopus
  12. J. A. Roberts, B. I. Marklund, D. Ilver et al., “The Gal(α1–4)Gal-specific tip adhesin of Escherichia coli P-fimbriae is needed for pyelonephritis to occur in the normal urinary tract,” Proceedings of the National Academy of Sciences of the United States of America, vol. 91, no. 25, pp. 11889–11893, 1994. View at Publisher · View at Google Scholar · View at Scopus
  13. P. Goluszko, S. L. Moseley, L. D. Truong et al., “Development of experimental model of chronic pyelonephritis with Escherichia coli O75:K5:H-bearing Dr fimbriae: mutation in the dra region prevented tubulointerstitial nephritis,” The Journal of Clinical Investigation, vol. 99, no. 7, pp. 1662–1672, 1997. View at Publisher · View at Google Scholar · View at Scopus
  14. J. F. van den Bosch, L. Emödy, and I. Kétyi, “Virulence of haemolytic strains of Escherichia coli in various animal models,” FEMS Microbiology Letters, vol. 13, no. 4, pp. 427–430, 1982. View at Publisher · View at Google Scholar · View at Scopus
  15. R. A. Welch, E. P. Dellinger, B. Minshew, and S. Falkow, “Haemolysin contributes to virulence of extra-intestinal E. coli infections,” Nature, vol. 294, no. 5842, pp. 665–667, 1981. View at Scopus
  16. K. E. Rippere-Lampe, A. D. O'Brien, R. Conran, and H. A. Lockman, “Mutation of the gene encoding cytotoxic necrotizing factor type 1 (cnf1) attenuates the virulence of uropathogenic Escherichia coli,” Infection and Immunity, vol. 69, no. 6, pp. 3954–3964, 2001. View at Publisher · View at Google Scholar · View at Scopus
  17. M. C. Lane, V. Lockatell, G. Monterosso et al., “Role of motility in the colonization of uropathogenic Escherichia coli in the urinary tract,” Infection and Immunity, vol. 73, no. 11, pp. 7644–7656, 2005. View at Publisher · View at Google Scholar · View at Scopus
  18. F. K. Bahrani-Mougeot, E. L. Buckles, C. V. Lockatell et al., “Type 1 fimbriae and extracellular polysaccharides are preeminent uropathogenic Escherichia coli virulence determinants in the murine urinary tract,” Molecular Microbiology, vol. 45, no. 4, pp. 1079–1093, 2002. View at Publisher · View at Google Scholar · View at Scopus
  19. J. D. Schilling, M. A. Mulvey, C. D. Vincent, R. G. Lorenz, and S. J. Hultgren, “Bacterial invasion augments epithelial cytokine responses to Escherichia coli through a lipopolysaccharide-dependent mechanism,” The Journal of Immunology, vol. 166, no. 2, pp. 1148–1155, 2001. View at Scopus
  20. A. G. Torres, P. Redford, R. A. Welch, and S. M. Payne, “TonB-dependent systems of uropathogenic Escherichia coli aerobactin and heme transport and TonB are required for virulence in the mouse,” Infection and Immunity, vol. 69, no. 10, pp. 6179–6185, 2001. View at Publisher · View at Google Scholar · View at Scopus
  21. E. C. Hagan and H. L. T. Mobley, “Uropathogenic Escherichia coli outer membrane antigens expressed during urinary tract infection,” Infection and Immunity, vol. 75, no. 8, pp. 3941–3949, 2007. View at Publisher · View at Google Scholar · View at Scopus
  22. B. W. Trautner, R. A. Hull, and R. O. Darouiche, “Colicins prevent colonization of urinary catheters,” Journal of Antimicrobial Chemotherapy, vol. 56, no. 2, pp. 413–415, 2005. View at Publisher · View at Google Scholar · View at Scopus
  23. E. Cascales, S. K. Buchanan, D. Duché et al., “Colicin biology,” Microbiology and Molecular Biology Reviews, vol. 71, no. 1, pp. 158–229, 2007. View at Publisher · View at Google Scholar · View at Scopus
  24. K. Gupta, D. Scholes, and W. E. Stamm, “Increasing prevalence of antimicrobial resistance among uropathogens causing acute uncomplicated cystitis in women,” The Journal of the American Medical Association, vol. 281, no. 8, pp. 736–738, 1999. View at Publisher · View at Google Scholar · View at Scopus
  25. J. D. D. Pitout, P. Nordmann, K. B. Laupland, and L. Poirel, “Emergence of Enterobacteriaceae producing extended-spectrum β-lactamases (ESBLs) in the community,” Journal of Antimicrobial Chemotherapy, vol. 56, no. 1, pp. 52–59, 2005. View at Publisher · View at Google Scholar · View at Scopus
  26. J. Rodriguez-Baño and D. L. Paterson, “A change in the epidemiology of infections due to extended-spectrum β-lactamase—producing organisms,” Clinical Infectious Diseases, vol. 42, no. 7, pp. 935–937, 2006. View at Publisher · View at Google Scholar · View at Scopus
  27. D. L. Paterson and R. A. Bonomo, “Extended-spectrum β-lactamases: a clinical update,” Clinical Microbiology Reviews, vol. 18, no. 4, pp. 657–686, 2005. View at Publisher · View at Google Scholar · View at Scopus
  28. J. D. D. Pitout and K. B. Laupland, “Extended-spectrum β-lactamase-producing Enterobacteriaceae: an emerging public-health concern,” The Lancet Infectious Diseases, vol. 8, no. 3, pp. 159–166, 2008. View at Publisher · View at Google Scholar · View at Scopus
  29. M. A. D. Antonio, S. E. Hawes, and S. L. Hillier, “The identification of vaginal Lactobacillus species and the demographic and microbiologic characteristics of women colonized by these species,” The Journal of Infectious Diseases, vol. 180, no. 6, pp. 1950–1956, 1999. View at Publisher · View at Google Scholar · View at Scopus
  30. B. Aslim and E. Kilic, “Some probiotic properties of vaginal Lactobacilli isolated from healthy women,” Japanese Journal of Infectious Diseases, vol. 59, no. 4, pp. 249–253, 2006. View at Scopus
  31. R. A. MacPhee, R. Hummelen, J. E. Bisanz, W. L. Miller, and G. Reid, “Probiotic strategies for the treatment and prevention of bacterial vaginosis,” Expert Opinion on Pharmacotherapy, vol. 11, no. 18, pp. 2985–2995, 2010. View at Publisher · View at Google Scholar · View at Scopus
  32. W. M. Russell and T. R. Klaenhammer, “Efficient system for directed integration into the Lactobacillus acidophilus and Lactobacillus gasseri chromosomes via homologous recombination,” Applied and Environmental Microbiology, vol. 67, no. 9, pp. 4361–4364, 2001. View at Publisher · View at Google Scholar · View at Scopus
  33. M. Zozaya-Hinchliffe, R. Lillis, D. H. Martin, and M. J. Ferris, “Quantitative PCR assessments of bacterial species in women with and without bacterial vaginosis,” Journal of Clinical Microbiology, vol. 48, no. 5, pp. 1812–1819, 2010. View at Publisher · View at Google Scholar · View at Scopus
  34. C. A. Elkins, M. E. Muñoz, L. B. Mullis, R. L. Stingley, and M. E. Hart, “Lactobacillus-mediated inhibition of clinical toxic shock syndrome Staphylococcus aureus strains and its relation to acid and peroxide production,” Anaerobe, vol. 14, no. 5, pp. 261–267, 2008. View at Publisher · View at Google Scholar · View at Scopus
  35. J. M. Laughton, E. Devillard, D. E. Heinrichs, G. Reid, and J. K. McCormick, “Inhibition of expression of a staphylococcal superantigen-like protein by a soluble factor from Lactobacillus reuteri,” Microbiology, vol. 152, no. 4, pp. 1155–1167, 2006. View at Publisher · View at Google Scholar · View at Scopus
  36. V. S. Ocaña, A. A. P. de Ruiz Holgado, and M. E. Nader-Macías, “Characterization of a bacteriocin-like substance produced by a vaginal Lactobacillus salivarius strain,” Applied and Environmental Microbiology, vol. 65, no. 12, pp. 5631–5635, 1999. View at Scopus
  37. J. Osset, R. M. Bartolomé, E. García, and A. Andreu, “Assessment of the capacity of Lactobacillus to inhibit the growth of uropathogens and block their adhesion to vaginal epithelial cells,” The Journal of Infectious Diseases, vol. 183, no. 3, pp. 485–491, 2001. View at Publisher · View at Google Scholar · View at Scopus
  38. M. C. Otero and M. E. Nader-Macías, “Inhibition of Staphylococcus aureus by H2O2-producing Lactobacillus gasseri isolated from the vaginal tract of cattle,” Animal Reproduction Science, vol. 96, no. 1, pp. 35–46, 2006. View at Publisher · View at Google Scholar · View at Scopus
  39. M. E. Falagas, G. I. Betsi, and S. Athanasiou, “Probiotics for the treatment of women with bacterial vaginosis,” Clinical Microbiology and Infection, vol. 13, no. 7, pp. 657–664, 2007. View at Publisher · View at Google Scholar · View at Scopus
  40. V. Redondo-Lopez, R. L. Cook, and J. D. Sobel, “Emerging role of lactobacilli in the control and maintenance of the vaginal bacterial microflora,” Reviews of Infectious Diseases, vol. 12, no. 5, pp. 856–872, 1990. View at Scopus
  41. G. Reid, J. Dols, and W. Miller, “Targeting the vaginal microbiota with probiotics as a means to counteract infections,” Current Opinion in Clinical Nutrition and Metabolic Care, vol. 12, no. 6, pp. 583–587, 2009. View at Publisher · View at Google Scholar · View at Scopus
  42. G. Reid, J. Jass, M. T. Sebulsky, and J. K. McCormick, “Potential uses of probiotics in clinical practice,” Clinical Microbiology Reviews, vol. 16, no. 4, pp. 658–672, 2003. View at Publisher · View at Google Scholar · View at Scopus
  43. F. K. Beller and K. W. Schweppe, “Review on the biology of menstrual blood,” in The Biology of the Fluids of the Female Genital Tract, F. K. Beller and G. G. B. Schumacher, Eds., pp. 231–245, North-Holland, New York, NY, USA, 1979.
  44. D. R. Hill, M. E. Brunner, D. C. Schmitz et al., “In vivo assessment of human vaginal oxygen and carbon dioxide levels during and post menses,” Journal of Applied Physiology, vol. 99, no. 4, pp. 1582–1591, 2005. View at Publisher · View at Google Scholar · View at Scopus
  45. G. L. D. S. Santiago, P. Cools, H. Verstraelen et al., “Longitudinal study of the dynamics of vaginal microflora during two consecutive menstrual cycles,” PLoS ONE, vol. 6, no. 11, Article ID e28180, 2011. View at Publisher · View at Google Scholar · View at Scopus
  46. F. E. A. Keane, C. A. Ison, and D. Taylor-Robinson, “A longitudinal study of the vaginal flora over a menstrual cycle,” International Journal of STD and AIDS, vol. 8, no. 8, pp. 489–494, 1997. View at Publisher · View at Google Scholar · View at Scopus
  47. D. A. Eschenbach, S. S. Thwin, D. L. Patton et al., “Influence of the normal menstrual cycle on vaginal tissue, discharge, and microflora,” Clinical Infectious Diseases, vol. 30, no. 6, pp. 901–907, 2000. View at Publisher · View at Google Scholar · View at Scopus
  48. S. Srinivasan, C. Liu, C. M. Mitchell et al., “Temporal variability of human vaginal bacteria and relationship with bacterial vaginosis,” PLoS ONE, vol. 5, no. 4, Article ID e10197, 2010. View at Publisher · View at Google Scholar · View at Scopus
  49. J. Sambrook, E. F. Fritsch, and T. Maniatis, Molecular Cloning: A Laboratory Manual, Cold Spring Harbor Laboratory, Cold Spring Harbor, NY, USA, 2nd edition, 1989.
  50. S. E. Murinda, R. F. Roberts, and R. A. Wilson, “Evaluation of colicins for inhibitory activity against diarrheagenic Escherichia coli strains, including serotype O157:H7,” Applied and Environmental Microbiology, vol. 62, no. 9, pp. 3196–3202, 1996. View at Scopus
  51. J. Aarnikunnas, N. von Weymarn, K. Rönnholm, M. Leisola, and A. Palva, “Metabolic engineering of Lactobacillus fermentum for production of mannitol and pure L-lactic acid or pyruvate,” Biotechnology and Bioengineering, vol. 82, no. 6, pp. 653–663, 2003. View at Publisher · View at Google Scholar · View at Scopus
  52. R. W. Jack, J. R. Tagg, and B. Ray, “Bacteriocins of gram-positive bacteria,” Microbiological Reviews, vol. 59, no. 2, pp. 171–200, 1995. View at Scopus
  53. U. K. Laemmli, “Cleavage of structural proteins during the assembly of the head of bacteriophage T4,” Nature, vol. 227, pp. 680–685, 1970. View at Publisher · View at Google Scholar · View at Scopus
  54. D. J. Evans Jr., D. G. Evans, A. R. Opekun, and D. Y. Graham, “Immunoprotective oral whole cell vaccine for enterotoxigenic Escherichia coli diarrhea prepared by in situ destruction of chromosomal and plasmid DNA with colicin E2,” FEMS Microbiology Immunology, vol. 1, no. 1, pp. 9–18, 1988. View at Scopus
  55. E. Cascales, S. K. Buchanan, D. Duché et al., “Colicin biology,” Microbiology and Molecular Biology Reviews, vol. 71, no. 1, pp. 158–229, 2007. View at Publisher · View at Google Scholar · View at Scopus
  56. L. O'Sullivan, R. P. Ross, and C. Hill, “Potential of bacteriocin-producing lactic acid bacteria for improvements in food safety and quality,” Biochimie, vol. 84, no. 5-6, pp. 593–604, 2002. View at Publisher · View at Google Scholar · View at Scopus
  57. C. Wandersman, “Secretion across the bacterial outer membrane,” Trends in Genetics, vol. 8, no. 9, pp. 317–322, 1992. View at Scopus
  58. A. P. Pugsley and J. P. Rosenbusch, “Release of colicin E2 from Escherichia coli,” Journal of Bacteriology, vol. 147, no. 1, pp. 186–192, 1981. View at Scopus
  59. A. P. Pugsley and M. Schwartz, “Expression of a gene in a 400-base-pair fragment of colicin plasmid ColE2-P9 is sufficient to cause host cell lysis,” Journal of Bacteriology, vol. 156, no. 1, pp. 109–114, 1983. View at Scopus
  60. A. P. Pugsley and M. Schwartz, “Colicin E2 release: lysis, leakage or secretion? Possible role of a phospholipase,” The EMBO Journal, vol. 3, no. 10, pp. 2393–2397, 1984. View at Scopus
  61. S. T. Cole, B. Saint-Joanis, and A. P. Pugsley, “Molecular characterisation of the colicin E2 operon and identification of its products,” Molecular and General Genetics, vol. 198, no. 3, pp. 465–472, 1985. View at Scopus
  62. S. Kanoh, H. Masaki, S. Yajima, T. Ohta, and T. Uozumi, “Signal peptide of the colicin E2 lysis protein causes host cell death,” Agricultural and Biological Chemistry, vol. 55, no. 6, pp. 1607–1614, 1991. View at Scopus
  63. D. Cavard and B. Oudega, “General introduction to the secretion of bacteriocins,” in Bacteriocins, Microcins, and Lantibiotics, R. James, C. Lazdunski, and F. Pattus, Eds., pp. 297–305, Springer, Berlin, Germany, 1992.
  64. V. Braun, H. Pilsl, and P. Gross, “Colicins: structures, modes of action, transfer through membranes, and evolution,” Archives of Microbiology, vol. 161, no. 3, pp. 199–206, 1994. View at Publisher · View at Google Scholar · View at Scopus
  65. H. Liu, Y. Gao, L.-R. Yu, R. C. Jones, C. A. Elkins, and M. E. Hart, “Inhibition of Staphylococcus aureus by lysostaphin-expressing Lactobacillus plantarum WCFS1 in a modified genital tract secretion medium,” Applied and Environmental Microbiology, vol. 77, no. 24, pp. 8500–8508, 2011. View at Publisher · View at Google Scholar · View at Scopus
  66. J. J. Liu, G. Reid, Y. Jiang, M. S. Turner, and C.-C. Tsai, “Activity of HIV entry and fusion inhibitors expressed by the human vaginal colonizing probiotic Lactobacillus reuteri RC-14,” Cellular Microbiology, vol. 9, no. 1, pp. 120–130, 2007. View at Publisher · View at Google Scholar · View at Scopus
  67. G. Reid, D. Charbonneau, J. Erb et al., “Oral use of Lactobacillus rhamnosus GR-1 and L. fermentum RC-14 significantly alters vaginal flora: randomized, placebo-controlled trial in 64 healthy women,” FEMS Immunology and Medical Microbiology, vol. 35, no. 2, pp. 131–134, 2003. View at Publisher · View at Google Scholar · View at Scopus